Bad ideas have a way of sticking around , but fortunately there’s a home for them called Congress. The recently proposed legislation on drug prices is firmly in this category, relying on what are in effect government-imposed price controls, backed by the threat of […]
Tag: pharmaceuticals
Protecting IP is critical to the fight against disease
With the world confronting daunting new health challenges, the UN is emphasizing the need to achieve true universal healthcare. That’s a laudable goal worth supporting — but the same can’t be said for the UN and other global organizations frequent support for measures that jeopardize […]
TES Weekly Update: Diabetes breakthrough promises healthier lives for millions
Editor’s Note: And undermining IP laws promises opposite Have you ever noticed that “fake news” almost always means bad news? Of course it’s taken for granted that “real news” usually means the same. Well, here’s that rarest of treasures, a piece of news that is both real and good, which frankly everyone should be […]
Africa’s digital healthcare revolution, in six steps
It was tempting to write “six easy steps” but that would be grossly inaccurate. Nonetheless the rapid rise of digital technology hold out the promise of improvements in healthcare provision that were unimaginable even a decade ago, writes Novartis head of global health […]
Fighting child trafficking, helping small IP owners & more: WASHINGTON BEYOND THE HEADLINES
By Andy Blom, TES Contributor Wow! Everybody was unhappy last week in Washington. The much hoped for Mueller testimony blew up in the Democrats face while Conservatives got served a budget and spending bill they hate…which will keep the Government open until after the election. Maybe we were doing better with the […]
Lilly CEO: Rebate reform wills save big on prescription drugs
The Trump Administration proposed new rules for pharmacy benefits managers promises to save Americans billions of dollars thanks to lower prices for prescription drugs, according to Eli Lilly CEO David Ricks, writing in an op-ed for USA Today. The proposed rule would require rebates from pharmaceutical companies to health insurance plans […]
WASHINGTON BEYOND THE HEADLINES: CEI tackles climate ideology and more…
By Andy Blom, TES Contributor While we wait for the chaos of the first Democratic Presidential Debate and watch the increasingly insane socialist, high tax social engineering and environmental doomsday proposals being put forth, free market conservatives are working every day on legislation, policy initiatives and practical approaches. Here’s a roundup of this […]
EU jeopardizing innovation with IP threats
Philip Stevens, Executive Director, Geneva Network. The European Parliament in April voted through a proposal that will allow generic companies to manufacture and export outside the EU copies of medicines that are still essentially patent protected in Europe. This vote around what’s known as the Supplementary Protection Certificate (SPC) Export Waiver may […]
Protect IP or give up miracle cures yet uninvented
In a piece for the Morning Consult, Philip Thompson of the Property Rights Alliance highlights the importance of intellectual property in powering innovation, especially in key categories like medicine: Ja’Ceon Golden, a “bubble boy” cured with healthy genes delivered via a “hijacked” (and otherwise harmless) HIV virus, is a poster boy for medical innovation. […]
DELINKAGE: CAN PRIZES REPLACE PATENTS FOR MEDICINE INNOVATION?
By Philip Stevens, Executive Director, Geneva Network Republished with permission of the Geneva Network. Original available here. The patent-based system of drug development comes under further pressure from key countries aiming to increase access to medicines at a joint World Health Organization and Government of India meeting in New Delhi this week. […]